Michael Celano Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Michael Celano.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Michael Celano. Michael Celano is Director in ORASURE TECHNOLOGIES INC ($OSUR) and Chief Financial Officer in Larimar Therapeutics, Inc. ($ZFGN) and Chief Financial Officer in Recro Pharma, Inc. ($REPH) and Chief Operating Officer in Recro Pharma, Inc. ($REPH).
Latest Insider Trading Transactions of Michael Celano
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, LRMR, OSUR, REPH
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 21 2021 | ZFGN | Larimar Therapeuti ... | Celano Michael | Chief Financial Off ... | Option Exercise | A | 19.61 | 42,000 | 823,620 | 42,000 | |
| Sep 30 2020 | ZFGN | Larimar Therapeuti ... | Celano Michael | Chief Financial Off ... | Option Exercise | A | 11.90 | 84,100 | 1,000,790 | 84,100 | |
| Jun 05 2020 | ZFGN | Larimar Therapeuti ... | Celano Michael | Chief Financial Off ... | Option Exercise | A | 11.88 | 60,479 | 718,491 | 60,479 | |
| May 19 2020 | OSUR | ORASURE TECHNOLOGI ... | Celano Michael | Director | Grant | A | 15.97 | 8,143 | 130,003 | 66,942 | 58.8 K to 66.9 K (+13.85 %) |
| May 19 2020 | OSUR | ORASURE TECHNOLOGI ... | Celano Michael | Director | Payment of Exercise | F | 16.04 | 3,843 | 61,642 | 58,799 | 62.6 K to 58.8 K (-6.13 %) |
| May 19 2020 | OSUR | ORASURE TECHNOLOGI ... | Celano Michael | Director | Grant | A | 15.97 | 8,143 | 130,003 | 66,942 | 58.8 K to 66.9 K (+13.85 %) |
| May 19 2020 | OSUR | ORASURE TECHNOLOGI ... | Celano Michael | Director | Payment of Exercise | F | 16.04 | 3,843 | 61,642 | 58,799 | 62.6 K to 58.8 K (-6.13 %) |
| May 22 2019 | OSUR | ORASURE TECHNOLOGI ... | Celano Michael | Director | Grant | A | 8.48 | 15,330 | 129,998 | 62,642 | 47.3 K to 62.6 K (+32.40 %) |
| Jan 23 2019 | REPH | Recro Pharma, Inc. | Celano Michael | Chief Operating Off ... | Option Exercise | M | 0.00 | 6,400 | 0 | 12,800 | |
| Jan 23 2019 | REPH | Recro Pharma, Inc. | Celano Michael | Chief Operating Off ... | Option Exercise | A | 7.99 | 60,592 | 484,130 | 60,592 | |
| Jan 23 2019 | REPH | Recro Pharma, Inc. | Celano Michael | Chief Operating Off ... | Payment of Exercise | F | 7.99 | 1,782 | 14,238 | 44,063 | 45.8 K to 44.1 K (-3.89 %) |
| Jan 23 2019 | REPH | Recro Pharma, Inc. | Celano Michael | Chief Operating Off ... | Buy | M | 0.00 | 6,400 | 0 | 45,845 | 39.4 K to 45.8 K (+16.23 %) |
| Jan 23 2019 | REPH | Recro Pharma, Inc. | Celano Michael | Chief Operating Off ... | Grant | A | 0.00 | 12,672 | 0 | 39,445 | 26.8 K to 39.4 K (+47.33 %) |
| Jan 04 2019 | REPH | Recro Pharma, Inc. | Celano Michael | Chief Operating Off ... | Payment of Exercise | F | 7.41 | 1,702 | 12,612 | 26,773 | 28.5 K to 26.8 K (-5.98 %) |
| May 10 2018 | OSUR | ORASURE TECHNOLOGI ... | Celano Michael | Director | Grant | A | 0.00 | 7,762 | 0 | 48,890 | 41.1 K to 48.9 K (+18.87 %) |
| Apr 03 2018 | OSUR | ORASURE TECHNOLOGI ... | Celano Michael | Director | Option Exercise | A | 16.80 | 40,000 | 671,800 | 40,000 | |
| Jan 22 2018 | REPH | Recro Pharma, Inc. | Celano Michael | Chief Operating Off ... | Option Exercise | M | 0.00 | 6,400 | 0 | 19,200 | |
| Jan 22 2018 | REPH | Recro Pharma, Inc. | Celano Michael | Chief Operating Off ... | Payment of Exercise | F | 8.89 | 2,020 | 17,958 | 28,475 | 30.5 K to 28.5 K (-6.62 %) |
| Jan 22 2018 | REPH | Recro Pharma, Inc. | Celano Michael | Chief Operating Off ... | Buy | M | 0.00 | 6,400 | 0 | 30,495 | 24.1 K to 30.5 K (+26.56 %) |
| Jan 04 2018 | REPH | Recro Pharma, Inc. | Celano Michael | Chief Operating Off ... | Option Exercise | A | 9.04 | 40,000 | 361,600 | 40,000 | |
| Jan 04 2018 | REPH | Recro Pharma, Inc. | Celano Michael | Chief Operating Off ... | Grant | A | 0.00 | 20,000 | 0 | 24,095 | 4.1 K to 24.1 K (+488.40 %) |
| Oct 02 2017 | REPH | Recro Pharma, Inc. | Celano Michael | Chief Financial Off ... | Payment of Exercise | F | 9.04 | 1,905 | 17,221 | 4,095 | 6 K to 4.1 K (-31.75 %) |
| Oct 02 2017 | REPH | Recro Pharma, Inc. | Celano Michael | Chief Financial Off ... | Buy | M | 0.00 | 6,000 | 0 | 6,000 | 0 to 6 K |
| May 17 2017 | OSUR | ORASURE TECHNOLOGI ... | Celano Michael | Director | Grant | A | 0.00 | 6,295 | 0 | 41,128 | 34.8 K to 41.1 K (+18.07 %) |
| May 17 2017 | OSUR | ORASURE TECHNOLOGI ... | Celano Michael | Director | Payment of Exercise | F | 15.13 | 3,284 | 49,679 | 34,833 | 38.1 K to 34.8 K (-8.62 %) |
| May 09 2017 | OSUR | ORASURE TECHNOLOGI ... | Celano Michael | Director | Sell | S | 14.95 | 44,962 | 672,182 | 38,117 | 83.1 K to 38.1 K (-54.12 %) |
| Mar 06 2017 | OSUR | ORASURE TECHNOLOGI ... | Celano Michael | Director | Option Exercise | M | 8.06 | 15,000 | 120,825 | 0 | |
| Mar 06 2017 | OSUR | ORASURE TECHNOLOGI ... | Celano Michael | Director | Sell | S | 12.00 | 15,000 | 180,000 | 83,079 | 98.1 K to 83.1 K (-15.29 %) |
| Mar 06 2017 | OSUR | ORASURE TECHNOLOGI ... | Celano Michael | Director | Buy | M | 8.06 | 15,000 | 120,825 | 98,079 | 83.1 K to 98.1 K (+18.06 %) |
| Feb 02 2017 | OSUR | ORASURE TECHNOLOGI ... | Celano Michael | Director | Option Exercise | M | 8.28 | 15,000 | 124,125 | 0 | |
| Feb 02 2017 | OSUR | ORASURE TECHNOLOGI ... | Celano Michael | Director | Sell | S | 8.78 | 15,000 | 131,700 | 93,079 | 108.1 K to 93.1 K (-13.88 %) |
| Feb 02 2017 | OSUR | ORASURE TECHNOLOGI ... | Celano Michael | Director | Buy | M | 8.28 | 15,000 | 124,125 | 108,079 | 93.1 K to 108.1 K (+16.12 %) |
| Jan 20 2017 | REPH | Recro Pharma, Inc. | Celano Michael | Chief Financial Off ... | Option Exercise | A | 0.00 | 25,600 | 0 | 25,600 | |
| Jan 20 2017 | REPH | Recro Pharma, Inc. | Celano Michael | Chief Financial Off ... | Option Exercise | A | 7.33 | 35,800 | 262,414 | 35,800 | |
| Jul 05 2016 | REPH | Recro Pharma, Inc. | Celano Michael | Chief Financial Off ... | Option Exercise | A | 8.21 | 140,000 | 1,149,400 | 140,000 | |
| May 18 2016 | OSUR | ORASURE TECHNOLOGI ... | Celano Michael | Director | Grant | A | 0.00 | 11,700 | 0 | 93,079 | 81.4 K to 93.1 K (+14.38 %) |
| May 12 2016 | OSUR | ORASURE TECHNOLOGI ... | Celano Michael | Director | Payment of Exercise | F | 6.84 | 4,177 | 28,550 | 81,379 | 85.6 K to 81.4 K (-4.88 %) |
| May 13 2015 | OSUR | ORASURE TECHNOLOGI ... | Celano Michael | Director | Grant | A | 0.00 | 14,883 | 0 | 85,556 | 70.7 K to 85.6 K (+21.06 %) |
| May 13 2015 | OSUR | ORASURE TECHNOLOGI ... | Celano Michael | Director | Payment of Exercise | F | 5.53 | 3,645 | 20,157 | 70,673 | 74.3 K to 70.7 K (-4.90 %) |
| May 22 2014 | OSUR | ORASURE TECHNOLOGI ... | Celano Michael | Director | Grant | A | 0.00 | 12,987 | 0 | 74,318 | 61.3 K to 74.3 K (+21.18 %) |
| May 15 2014 | OSUR | ORASURE TECHNOLOGI ... | Celano Michael | Director | Payment of Exercise | F | 6.52 | 4,913 | 32,033 | 61,331 | 66.2 K to 61.3 K (-7.42 %) |
| May 16 2013 | OSUR | ORASURE TECHNOLOGI ... | Celano Michael | Director | Payment of Exercise | F | 4.50 | 2,485 | 11,170 | 66,244 | 68.7 K to 66.2 K (-3.62 %) |
| May 16 2013 | OSUR | ORASURE TECHNOLOGI ... | Celano Michael | Director | Grant | A | 0.00 | 17,505 | 0 | 68,729 | 51.2 K to 68.7 K (+34.17 %) |
| Feb 03 2012 | OSUR | ORASURE TECHNOLOGI ... | Celano Michael | Director | Grant | A | 0.00 | 8,854 | 0 | 51,224 | 42.4 K to 51.2 K (+20.90 %) |
| Feb 03 2012 | OSUR | ORASURE TECHNOLOGI ... | Celano Michael | Director | Payment of Exercise | F | 11.30 | 4,210 | 47,552 | 42,370 | 46.6 K to 42.4 K (-9.04 %) |
| Feb 03 2011 | OSUR | ORASURE TECHNOLOGI ... | Celano Michael | Director | Grant | A | 0.00 | 15,000 | 0 | 46,580 | 31.6 K to 46.6 K (+47.50 %) |
| Jan 26 2011 | OSUR | ORASURE TECHNOLOGI ... | Celano Michael | Director | Payment of Exercise | F | 6.57 | 4,210 | 27,660 | 31,580 | 35.8 K to 31.6 K (-11.76 %) |
| Jan 26 2010 | OSUR | ORASURE TECHNOLOGI ... | Celano Michael | Director | Grant | A | 0.00 | 15,000 | 0 | 35,790 | 20.8 K to 35.8 K (+72.15 %) |
| Jan 26 2010 | OSUR | ORASURE TECHNOLOGI ... | Celano Michael | Director | Payment of Exercise | F | 5.19 | 4,210 | 21,850 | 20,790 | 25 K to 20.8 K (-16.84 %) |
| Jan 27 2009 | OSUR | ORASURE TECHNOLOGI ... | Celano Michael | Director | Grant | A | 0.00 | 15,000 | 0 | 25,000 | 10 K to 25 K (+150.00 %) |
| Aug 14 2008 | OSUR | ORASURE TECHNOLOGI ... | Celano Michael | Director | Buy | P | 4.59 | 10,000 | 45,905 | 10,000 | 0 to 10 K |
| Feb 05 2008 | OSUR | ORASURE TECHNOLOGI ... | Celano Michael | Director | Option Exercise | A | 8.06 | 15,000 | 120,825 | 15,000 | |
| Feb 05 2007 | OSUR | ORASURE TECHNOLOGI ... | Celano Michael | Director | Option Exercise | A | 8.28 | 15,000 | 124,125 | 15,000 | |
| Oct 06 2006 | OSUR | ORASURE TECHNOLOGI ... | Celano Michael | Director | Option Exercise | A | 7.97 | 40,000 | 318,800 | 40,000 |
Page: 1